The title structures, [Zn2(C3H6NS2)4(C14H14N4O2)]·2C3H7NO (I) and [Zn2(C7H14NS2)4(C14H14N4O2)] (II), each feature a bidentate, bridging bipyridyl-type ligand encompassing a di-amide group. In (I), the binuclear compound is disposed about a centre of inversion, leading to an open conformation, while in (II), the complete mol-ecule is completed by the application of a twofold axis of symmetry so that the bridging ligand has a U-shape. In each of (I) and (II), the di-thio-carbamate ligands are chelating with varying degrees of symmetry, so the zinc atom is within an NS4 set approximating a square-pyramid for (I) and a trigonal-bipyramid for (II). The solvent di-methyl-formaide (DMF) mol-ecules in (I) connect to the bridging ligand via amide-N-H⋯O(DMF) and various amide-, DMF-C-H⋯O(amide, DMF) inter-actions. The resultant three-mol-ecule aggregates assemble into a three-dimensional architecture via C-H⋯π(pyridyl, chelate ring) inter-actions. In (II), undulating tapes sustained by amide-N-H⋯O(amide) hydrogen bonding lead to linear supra-molecular chains with alternating mol-ecules lying to either side of the tape; no further directional inter-actions are noted in the crystal.
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.